Concomitant Ankylosing Spondylitis and DISH
Overview
Authors
Affiliations
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.
Bahar M, Kim H, Kim D Signal Transduct Target Ther. 2023; 8(1):455.
PMID: 38105263 PMC: 10725898. DOI: 10.1038/s41392-023-01705-z.
Couto A, Parreira B, Power D, Pinheiro L, Dias J, Novofastovski I Front Genet. 2022; 13:987867.
PMID: 36276944 PMC: 9586552. DOI: 10.3389/fgene.2022.987867.
Pappone N, Di Minno M, Iervolino S, Lupoli R, Mader R, Zincarelli C Rheumatol Int. 2015; 35(12):2041-6.
PMID: 26048625 DOI: 10.1007/s00296-015-3303-4.
Diffuse idiopathic skeletal hyperostosis: differentiation from ankylosing spondylitis.
Olivieri I, DAngelo S, Palazzi C, Padula A, Mader R, Khan M Curr Rheumatol Rep. 2009; 11(5):321-8.
PMID: 19772826 DOI: 10.1007/s11926-009-0046-9.
Coexisting diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis.
Olivieri I Clin Rheumatol. 1991; 10(1):95.
PMID: 2065518 DOI: 10.1007/BF02208043.